1. Home
  2. BHVN vs STEW Comparison

BHVN vs STEW Comparison

Compare BHVN & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • STEW
  • Stock Information
  • Founded
  • BHVN 2013
  • STEW 1972
  • Country
  • BHVN United States
  • STEW United States
  • Employees
  • BHVN N/A
  • STEW N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • STEW Investment Managers
  • Sector
  • BHVN Health Care
  • STEW Finance
  • Exchange
  • BHVN Nasdaq
  • STEW Nasdaq
  • Market Cap
  • BHVN 1.9B
  • STEW 1.6B
  • IPO Year
  • BHVN 2017
  • STEW N/A
  • Fundamental
  • Price
  • BHVN $20.24
  • STEW $17.35
  • Analyst Decision
  • BHVN Strong Buy
  • STEW
  • Analyst Count
  • BHVN 14
  • STEW 0
  • Target Price
  • BHVN $62.92
  • STEW N/A
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • STEW 84.5K
  • Earning Date
  • BHVN 05-16-2025
  • STEW 01-01-0001
  • Dividend Yield
  • BHVN N/A
  • STEW 3.71%
  • EPS Growth
  • BHVN N/A
  • STEW N/A
  • EPS
  • BHVN N/A
  • STEW 1.44
  • Revenue
  • BHVN N/A
  • STEW N/A
  • Revenue This Year
  • BHVN N/A
  • STEW N/A
  • Revenue Next Year
  • BHVN $65.26
  • STEW N/A
  • P/E Ratio
  • BHVN N/A
  • STEW $10.34
  • Revenue Growth
  • BHVN N/A
  • STEW N/A
  • 52 Week Low
  • BHVN $15.79
  • STEW $11.97
  • 52 Week High
  • BHVN $55.70
  • STEW $14.94
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.79
  • STEW 58.96
  • Support Level
  • BHVN $18.75
  • STEW $16.76
  • Resistance Level
  • BHVN $24.06
  • STEW $17.59
  • Average True Range (ATR)
  • BHVN 2.00
  • STEW 0.26
  • MACD
  • BHVN 0.21
  • STEW 0.04
  • Stochastic Oscillator
  • BHVN 42.39
  • STEW 80.24

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About STEW SRH Total Return Fund Inc.

SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.

Share on Social Networks: